Caprine Brucellosis: Diagnosis and Management

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Caprine brucellosis, caused by Brucella melitensis, is characterized by late-term abortions, stillbirths, and weak offspring, significantly impacting flock productivity and posing a high zoonotic risk to humans.
• Diagnosis relies on a tiered approach, commencing with screening tests like the Rose Bengal plate test (RBPT) or milk ring test, followed by confirmatory methods such as competitive ELISA, PCR, or bacterial culture, with culture being the definitive but hazardous gold standard.
• Effective management hinges on a multi-pronged strategy including rigorous test-and-removal of seropositive animals, stringent biosecurity measures to prevent introduction and spread, and judicious use of vaccination where permitted and epidemiologically indicated.
• Zoonotic risk reduction is paramount, necessitating clear communication of risks to owners and workers, mandatory pasteurization of all goat milk products, and the consistent use of personal protective equipment when handling potentially infectious materials.
• Differential diagnoses for caprine abortion are broad and include Chlamydia abortus, Coxiella burnetii, and toxoplasmosis, underscoring the need for comprehensive laboratory investigation to differentiate causes and guide appropriate management.
• Control programs must be sustained over multiple years, with ongoing surveillance and documentation of test results, animal movements, and clinical events, as a single negative test round does not guarantee freedom from infection.

Caprine brucellosis is a chronic infectious disease of goats caused by the gram-negative coccobacillus Brucella melitensis. The disease is characterized by middle- to late-term abortion, stillbirths, and delivery of weak offspring, and it produces extensive negative impacts on flock productivity. This article provides the practicing veterinarian with a diagnostic reasoning framework for suspect cases, an evidence-based approach to laboratory confirmation, and practical guidance for herd-level management and zoonotic risk reduction. It is written for clinicians who may encounter the disease in endemic regions or who must consider it in the differential diagnosis of caprine abortion in previously free areas.

B. melitensis is the most virulent Brucella species for humans, causing a debilitating illness with intermittent fever, chills, sweats, weakness, myalgia, and osteoarticular complications. The epidemiological link between Malta fever and consumption of goat milk was established in 1905, and goats have served as hosts of the organizm for centuries. The disease remains a significant burden in the Mediterranean region, the Middle East, Central and Southeast Asia, sub-Saharan Africa, and parts of Latin America, where an estimated 3.5 billion people live at risk. In contrast, several industrialized countries have successfully managed or eradicated the disease from domestic small ruminant populations.

At a Glance

Aetiology and Pathogenesis

Brucella melitensis is a facultative intracellular pathogen that survives and replicates within macrophages and placental trophoblasts. The organizm's lipopolysaccharide is a major virulence factor and the principal target of serological diagnostic tests. After oral or conjunctival exposure, the bacteria invade mucosal surfaces, are phagocytosed by macrophages, and disseminate via the lymphatic system to the reproductive tract and mammary gland. In pregnant animals, the organizm preferentially localizes in the placenta, where erythritol supports rapid bacterial growth, leading to placentitis, necrosis, and eventual abortion.

The incubation period is highly variable, ranging from several weeks to months. Abortion typically occurs between the third and fifth month of gestation, and the dam may shed large numbers of organizms in vaginal discharges, placental tissue, and milk for weeks to months after the event. A proportion of infected does abort only once and subsequently produce normal litters, which complicates clinical recognition of endemic infection within a herd. Persistently infected animals may shed organizms intermittently for life.

Epidemiology and Geographic Distribution

The global distribution of caprine brucellosis is uneven. Endemic regions include the Mediterranean basin, the Middle East, Central and Southeast Asia, sub-Saharan Africa, and parts of Latin America. Whole-genome sequencing of Italian isolates has demonstrated that the West Mediterranean lineage dominates in that country, with Sicily serving as a burden hotspot and more than 20 putative outbreak clusters persisting over an eight-year surveillance period despite eradication efforts. This work illustrates the value of molecular epidemiology for tracing outbreak origins and identifying persistent infection reservoirs.

In Central America, B. melitensis infection has been detected in Guatemala, while bovine and swine brucellosis are more widely distributed across the region. The prevalence of infection in small ruminants is often underestimated because clinical signs are subtle in non-pregnant animals and surveillance is limited. In Pakistan, serological screening of small ruminants in contact with infected bovine herds identified Brucella abortus as the causative agent, demonstrating that cross-species transmission occurs and that diagnostic testing should not assume a single species in mixed-species operations.

Wildlife may serve as incidental hosts or reservoirs. Molecular surveys in Germany, a country officially free of ovine and caprine brucellosis, have detected Brucella DNA in rodents and shrews, with sequence analysis revealing close relationships to a potentially novel species isolated from red foxes. The public health significance of these wildlife findings remains uncertain, but they indicate that environmental contamination and wildlife contact should be considered in outbreak investigations.

Clinical Presentation

The characteriztic clinical sign of caprine brucellosis is abortion in the last third of gestation. Does may also deliver stillborn kids or weak kids that fail to thrive. Retained placenta and metritis are common sequelae, and secondary bacterial infections may complicate the clinical picture. Orchitis and epididymitis occur in infected bucks, and the organizm can be shed in semen. Arthritis, particularly of the carpal joints, has been reported in some infected animals, although it is less common than in swine brucellosis.

Subclinical infection is the rule in non-pregnant animals and in herds with long-standing endemic infection. The absence of overt clinical signs in these settings means that serological screening is the only reliable method for detecting infection. Milk production losses and reduced fertility contribute to the economic impact of the disease, although these effects are difficult to quantify in extensively managed flocks.

The differential diagnosis of caprine abortion includes Chlamydia abortus, Coxiella burnetii, toxoplasmosis, salmonellosis, and nutritional or management-related causes. A thorough abortion investigation should include fetal examination, placental evaluation, maternal serology, and appropriate laboratory testing to distinguish these causes. The zoonotic potential of B. melitensis, C. burnetii, and Chlamydia abortus makes personal protective equipment essential when handling abortion material.

Diagnostic Principles

Diagnosis of caprine brucellosis relies on a combination of serological testing, bacterial culture, and molecular methods. The Rose Bengal plate test is a rapid, inexpensive screening test that detects antibodies against Brucella smooth lipopolysaccharide. It is well suited to field use and has acceptable sensitivity for screening purposes, but positive results require confirmation with a more specific test. The milk ring test can be used on bulk tank or individual milk samples and is particularly useful for surveillance in dairy herds.

Competitive ELISA formats offer improved specificity compared with indirect assays. A competitive ELISA developed using a monoclonal antibody against B. melitensis biotype 2 demonstrated 100% specificity and sensitivity at a defined cut-off point and did not cross-react with sera positive for antibodies to some Enterobacteriaceae. This assay performed favourably when compared with complement fixation and Rose Bengal tests and is a valuable confirmatory tool for ovine and caprine brucellosis.

PCR assays targeting the bcsp31 gene and the IS711 insertion sequence provide rapid species-level identification. Real-time PCR can distinguish B. abortus from B. melitensis using species-specific probes, which is clinically relevant in mixed-species operations. Bacterial culture remains the definitive diagnostic method and is required for biotyping and antimicrobial susceptibility testing, but it is slow, hazardous, and requires specialised laboratory facilities. Culture of B. melitensis should only be attempted in biosafety level 3 facilities.

Serological interpretation requires knowledge of the vaccination history and the epidemiological context. Vaccinated animals may test positive on serological assays, and the distinction between vaccine-induced and field-strain antibodies is not always possible with standard tests. The World Organization for Animal Health publishes international standards for diagnostic testing and surveillance, and veterinarians should consult these standards when designing testing protocols.

Diagnostic Testing Algorithm

The diagnostic approach to caprine brucellosis proceeds through a defined sequence that balances herd-level screening objectives against the need for confirmatory evidence in individual animals. The algorithm begins with risk assessment, moves to screening tests, and reserves confirmatory methods for cases where regulatory action, herd depopulation, or human exposure investigation is anticipated.

Step 1: Risk Stratification and Test Selection

The choice of initial test depends on the purpose of testing. Surveillance in a previously negative herd requires a test with high specificity to avoid false-positive reactions that trigger unnecessary regulatory action. Investigation of an abortion storm in an endemic region prioritizes sensitivity, because missing a single infected doe perpetuates flock-level transmission.

The Rose Bengal plate test (RBPT) remains the most widely used screening tool in field settings because it is inexpensive, rapid, and requires minimal laboratory infrastructure. A positive RBPT result should never be considered diagnostic in isolation. The complement fixation test (CFT) offers higher specificity and is the confirmatory serological method required by many national eradication programs. Competitive ELISA formats, such as the Brucella-Ab c-ELISA validated for ovine and caprine sera, provide specificity and sensitivity comparable to CFT while avoiding the cross-reactions with Enterobacteriaceae that complicate interpretation of indirect ELISA results.

Step 2: Confirmatory Testing

Seropositive animals should be subjected to confirmatory testing before any control decision is made. The confirmatory pathway depends on the tests available in the submitting laboratory:

• Where CFT is available, it serves as the primary confirmatory test for RBPT-positive sera.
• Where competitive ELISA is available, it may replace CFT for confirmatory purposes, particularly in laboratories that lack the complement reagents required for CFT.
• Bacteriological culture of uterine discharge, vaginal swabs, milk, or fetal stomach contents provides definitive confirmation but requires specialised biosafety facilities because B. melitensis is a WHO Risk Group 3 pathogen.
• PCR targeting the bcsp31 gene or IS711 insertion sequence can detect Brucella DNA in clinical samples and is particularly useful when culture is unavailable or when samples have been compromised by transport delays.

Step 3: Interpretation and Action Thresholds

Interpretation of serological results must account for the vaccination history of the herd. Vaccinated animals may remain seropositive for extended periods, and distinguishing vaccine-induced antibody from field infection requires either the use of tests that differentiate vaccine responses or the application of higher cut-off values. The competitive ELISA format has an advantage here because its monoclonal antibody target reduces the likelihood of false positives from cross-reacting organizms.

A single seropositive animal in a previously negative herd warrants immediate quarantine and confirmatory testing. Two or more seropositive animals in the same epidemiological group, particularly when accompanied by abortion history, constitute strong evidence of active infection and should trigger herd-level testing of all breeding animals.

Laboratory Techniques and Sample Handling

Sample Collection

The diagnostic yield of laboratory testing depends heavily on sample quality. Whole blood should be collected into plain tubes for serum separation. Milk samples for the milk ring test should be collected from individual does into sterile containers and refrigerated immediately. For bacteriological culture, the highest yield comes from fetal abomasal contents, fetal lung, placental cotyledons, and vaginal swabs collected within 48 hours of abortion. Samples for PCR should be collected into sterile containers without preservative and transported cold.

Test Performance Characteriztics

The milk ring test detects antibody in bulk or individual milk samples and provides a cost-effective screening method in lactating herds, but it cannot identify individual infected animals when used on bulk milk. PCR methods have the advantage of detecting the organizm directly instead of the host antibody response, which is particularly valuable in the early stages of infection before seroconversion is complete.

Control Plan Checklist

An effective control program for caprine brucellosis requires a structured approach that adapts to the epidemiological context. The following checklist provides a framework for the practising veterinarian:

Herd-Level Control Measures

• Establish the infection status of the herd through complete serological testing of all breeding animals over six months of age.
• Isolate all seropositive animals immediately and designate them for culling or segregation into a separate infected group.
• Test all animals that have had contact with seropositive individuals, including animals in adjacent pens and those sharing pasture.
• Repeat whole-herd testing at 30 to 60 day intervals until two consecutive negative tests are obtained.
• Quarantine the herd and prohibit sale or movement of breeding stock until the herd achieves negative status.
• Implement a vaccination program where national policy permits and where the epidemiological situation justifies its use.

Environmental and Management Measures

• Remove and dispose of aborted fetuses, placentas, and contaminated bedding by burial or incineration.
• Disinfect calving and kidding areas with appropriate disinfectants after each abortion event.
• Manage manure and effluent to prevent contamination of water sources and feed storage areas.
• Maintain closed-herd policies wherever possible, and test all incoming animals during a quarantine period of at least 30 days.
• Separate pregnant does from the main herd during the final trimester to limit contact between aborting and susceptible animals.

Zoonotic Risk Management

B. melitensis is the most virulent Brucella species for humans, causing a debilitating illness characterized by intermittent fever, chills, sweats, weakness, myalgia, and osteoarticular complications. The veterinarian has a professional obligation to communicate this risk clearly to owners and farm workers. Pasteurisation of all goat milk and milk products intended for human consumption is non-negotiable. Personnel handling aborting does, fetal material, or laboratory samples must wear gloves, protective outerwear, and eye protection. Any person with unexplained fever, malaise, or joint pain who has had contact with goats should be referred promptly for medical evaluation.

Regional and Regulatory Considerations

The regulatory framework governing brucellosis control varies substantially between jurisdictions. In countries with eradication programs, such as Italy, the disease remains endemic in several southern provinces despite ongoing control efforts, and whole-genome sequencing has revealed persistent outbreak clusters that survive aggressive eradication campaigns. In Central America, national control programs based on calf vaccination and reactor removal have had limited impact, and unrestricted adult vaccination has been proposed as an alternative strategy. The veterinarian must consult the relevant national veterinary authority to determine the specific testing requirements, movement restrictions, and reporting obligations that apply in their region. The WOAH terrestrial animal health standards provide international guidance on surveillance and trade-related control measures.

Monitoring Parameters and Documentation

Effective monitoring requires defined parameters that are assessed at regular intervals. The core monitoring parameters for a brucellosis control program are:

• Seroprevalence within the herd, expressed as the percentage of animals testing positive on screening tests.
• Abortion rate, calculated as the number of abortions per 100 confirmed pregnancies per year.
• Incidence of new seroconversions in previously negative animals.
• Compliance with testing schedules and movement restrictions.
• Human exposure incidents and occupational illness reports.

Documentation should include the date and result of every test performed, the identification of every animal tested, the laboratory and test method used, and the disposition of every positive animal. This record forms the basis for demonstrating herd status to regulatory authorities and for tracing infection sources in the event of an outbreak.

The persistence of infection despite control efforts is a recognized failure mode. In Italy, more than 20 putative outbreak clusters were identified over an eight-year surveillance period, several of which persisted despite aggressive eradication campaigns. The veterinarian should anticipate that a single negative test round does not guarantee freedom from infection, particularly in herds with a history of abortion storms or in regions where wildlife reservoirs may exist. Molecular surveys have detected Brucella DNA in rodents and shrews in Germany, raising questions about the role of small mammals in maintaining infection cycles. The practical implication is that control programs must be sustained over multiple years and that surveillance must continue after apparent eradication is achieved.

Recognized Complications and Failure Modes

The most consequential failure in caprine brucellosis management is the missed abortion storm. A single abortion in a naive flock can seed widespread contamination before seroconversion is detectable, and the interval between exposure and detectable antibody can exceed the period during which the producer would normally seek investigation. Early detection depends on maintaining a low threshold for testing any abortion, stillbirth, or weak kid, particularly in regions where caprine brucellosis remains a significant burden on goat and human health.

Chronic flock infection represents a second failure mode. When brucellosis becomes endemic within a herd, the characteriztic abortion storm may no longer occur. Instead, the clinician observes sporadic abortions, reduced kidding rates, and increased neonatal mortality. These signs are easily attributed to other causes, including nutritional deficiency, toxoplasmosis, or chlamydial abortion. The discriminating finding is the persistence of seropositive animals across multiple kidding seasons despite apparent clinical improvement.

A third failure mode is the false sense of security after a single negative test round. Serological testing identifies antibody, not infection, and recently exposed animals may test negative during the incubation period. A single clean test result does not establish flock freedom. The Society for Theriogenology resources emphasize that reproductive disease investigation requires a systematic approach, and brucellosis screening should be repeated after a defined interval before a negative status is accepted.

Common Diagnostic Errors

The most frequent error in practice is over-reliance on a single serological test. The Rose Bengal test is a screening tool with excellent sensitivity in acutely infected flocks, but it can produce false positives from cross-reacting organizms, including certain Enterobacteriaceae. A positive Rose Bengal result must be confirmed with a more specific assay. The competitive ELISA developed for ovine, caprine, and bovine brucellosis demonstrated no cross-reactions with Enterobacteriaceae when compared with an indirect ELISA, making it a suitable confirmatory test.

A second error is sampling the wrong animals. Testing only aborting does will miss the infected but clinically normal carriers that maintain the disease within the flock. Sampling should include the entire breeding herd, with particular attention to recently introduced animals and bucks, which can serve as silent shedders.

A third error is poor sample handling. Brucella organizms are fastidious and easily overgrown by contaminating bacteria. Blood cultures must be inoculated into appropriate media promptly, and tissue samples for PCR must be stored correctly to preserve nucleic acid. The molecular survey of brucellosis in rodents and shrews demonstrated that PCR-based detection is feasible on tissue samples, but the reliability of the result depends on sample quality.

A fourth error is failure to consider Brucella abortus as a possible cause of caprine infection. While B. melitensis is the classic caprine pathogen, serological, cultural, and molecular evidence from Pakistan identified B. abortus as the causative agent of ovine and caprine brucellosis in that setting. The diagnostic plan should therefore include species-level identification when culture or PCR is performed.

Troubleshooting Table

Limitations of Current Evidence

The evidence base for caprine brucellosis is uneven. Much of the published literature derives from regions where the disease is endemic, and the diagnostic test performance figures reported in those settings may not transfer directly to low-prevalence populations. The evolutionary history and current distribution of B. melitensis in Italy illustrates that whole-genome sequencing can reveal persistent outbreak clusters even in countries with aggressive eradication programs, but the practical implications for individual herd management remain uncertain.

Expert opinion differs on the value of vaccination in endemic settings. Some authorities advocate vaccination as a primary control tool, while others argue that test-and-removal is the only route to eradication. The experience in Central America suggests that vaccination programs have had limited impact when not combined with rigorous reactor removal, but the optimal balance between these strategies depends on local prevalence, resources, and regulatory frameworks.

The zoonotic risk is well documented, but the occupational exposure pathways in modern intensive goat production are less well characterized than in traditional smallholder systems. Clinicians should assume that any confirmed case carries zoonotic potential and act accordingly.

Referral and Reporting Thresholds

Referral to a specialist laboratory is indicated when serological results are discordant, when species-level identification is required for epidemiological purposes, or when the clinician lacks the facilities for safe culture of Brucella organizms. Laboratory involvement is also appropriate when investigating a suspected outbreak, because the laboratory can provide the confirmatory testing and molecular typing needed to support a regulatory response.

Regulatory reporting is mandatory in most jurisdictions where brucellosis is a notifiable disease. The WOAH terrestrial animal health standards define the international framework for surveillance and trade-related control, and clinicians should familiarise themselves with the requirements of their local competent authority. Failure to report a confirmed case can prolong the outbreak and increase the zoonotic risk to farm workers and the wider community.

Specialist consultation is warranted when the clinician is unfamiliar with the regulatory framework, when the flock is large or valuable, or when the producer is resistant to the recommended control measures. A veterinary epidemiologist or regulatory veterinarian can provide the additional authority and resources needed to implement an effective control program.

Frequently Asked Questions

How should I proceed when confirmatory laboratory testing is unavailable or prohibitively expensive?

When culture, PCR, or confirmatory serology is not accessible, base the working diagnosis on compatible clinical signs, herd history, and screening serology. Rose Bengal plate testing is inexpensive and suitable for herd-level screening, but positive results require cautious interpretation because cross-reactions occur. A competitive ELISA offers improved specificity and can be used where available, as it does not demonstrate cross-reactions with some Enterobacteriaceae that confound other assays (competitive ELISA validation data). If confirmatory testing is impossible, manage the herd as suspect-positive, apply strict biosecurity, and notify the relevant animal health authority, since brucellosis is reportable in most jurisdictions. Repeat screening after 30 to 60 days to identify seroconversion.

What is the minimum equipment needed to collect diagnostic samples safely in a field setting?

Safe field sampling requires personal protective equipment, including gloves, eye protection, and a mask, because B. melitensis is the most virulent Brucella species for humans (caprine brucellosis public health impact). For serology, collect blood into plain tubes using standard venipuncture. For bacteriology, collect abortion material, placental cotyledons, vaginal swabs, and fetal abomasal contents into sterile containers with transport medium if culture is planned. A centrifuge is needed to separate serum, although whole blood can be submitted if the laboratory accepts it. When a centrifuge is unavailable, allow samples to clot, refrigerate, and submit promptly. Milk samples for the milk ring test require only sterile collection tubes. Label every sample with animal identification and collection date.

How do I distinguish caprine brucellosis from other common causes of goat abortion?

Brucellosis typically causes abortion in the last third of gestation, with retained placenta and subsequent weak kids (clinical features of caprine brucellosis). Other causes include toxoplasmosis, chlamydiosis, Coxiella burnetii, leptospirosis, and nutritional deficiencies. Toxoplasmosis often causes earlier abortion with mummified fetuses. Chlamydiosis produces placentitis with thickened, discoloured cotyledons. Q fever causes late abortion and is also zoonotic. Serology and PCR on fetal and placental tissues differentiate these agents. Brucellosis should be suspected when multiple does abort in late gestation, when abortion storms occur, and when there is a history of introduced animals. Confirmatory diagnosis requires laboratory testing, since clinical signs alone are insufficient.

What records should I maintain for a herd under brucellosis investigation or control?

Maintain individual animal identification, abortion history, breeding dates, and test results for every doe. Record the date, test type, laboratory, and result for each serological sample. Document movement of animals onto and off the property, including source herds and health status. Keep a log of clinical signs, especially abortions, stillbirths, and weak kids, with the gestational stage at loss. Record biosecurity measures, disinfection procedures, and isolation protocols. These records support epidemiological tracing and demonstrate compliance with control programs. In regions with eradication campaigns, accurate records are essential for maintaining herd status and facilitating trade (ovine and caprine brucellosis eradication program data). Digital spreadsheets or paper logs are both acceptable, provided entries are consistent and contemporaneous.

How should I advise a client whose livelihood depends on a heavily infected flock?

Be direct about the zoonotic risk to the client, family members, and workers, since B. melitensis causes severe human illness with intermittent fever, myalgia, and endocarditis (public health burden of caprine brucellosis). Advise that pasteurisation of all milk products is mandatory and that protective clothing should be worn when handling abortion material. Explain that eradication from a heavily infected flock is prolonged and costly, and that test-and-slaughter may be economically devastating. Discuss the option of gradual replacement with seronegative stock, or depopulation followed by restocking, depending on regional regulations and compensation schemes. Refer the client to the relevant animal health authority early, because official programs may provide guidance and financial support.

How does the diagnostic approach differ when Brucella abortus is suspected instead of B. melitensis?

B. abortus infection in goats is uncommon but has been documented, including in Pakistan where small ruminants in contact with seropositive cattle were infected with B. abortus (Brucella infection in small ruminants). Clinical signs resemble those of B. melitensis infection. Screening tests detect antibodies to both species because they share lipopolysaccharide antigens. Species-specific PCR targeting IS711 differentiates B. abortus from B. melitensis and should be requested when culture or molecular testing is performed. The zoonotic risk is lower with B. abortus, but precautions remain necessary. Control measures are similar, although the source of infection may be shared grazing or co-housed cattle, so the investigation should extend to other ruminant species on the property.

Related Clinical & Scientific Guides

• Diagnostic Approach to Canine Infertility in the Bitch
• Canine Neonatal Resuscitation: Protocol and Monitoring
• Equine Breeding Soundness Examination of the Stallion

References and Further Reading

• Caprine brucellosis: A historically neglected disease with significant impact on public health.. 2017.
• Evolutionary history and current distribution of the West Mediterranean lineage of <i>Brucella melitensis</i> in Italy.. 2020.
• Brucellosis in Central America.. 2002.
• Serological, cultural, and molecular evidence of Brucella infection in small ruminants in Pakistan.. 2015.
• Development and validation of a competitive ELISA kit for the serological diagnosis of ovine, caprine and bovine brucellosis.. 2006.
• Molecular Survey on Brucellosis in Rodents and Shrews - Natural Reservoirs of Novel Brucella Species in Germany?. 2017.
• Society for Theriogenology Resources. Society for Theriogenology.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.

Related Articles

• Equine Brucellosis: Diagnosis and Management
• Ovine Brucellosis: Diagnosis and Management
• Feline Dystocia: Diagnosis and Management
• Dystocia in Mares: Diagnosis and Management
• Brucellosis in Cattle: Diagnosis and Control Strategies

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.